Free Trial

Brainstorm Cell Therapeutics (BCLI) SEC Filings & 10K Form

$0.54
-0.04 (-6.93%)
(As of 05/24/2024 ET)

Recent Brainstorm Cell Therapeutics SEC Filings

DateFilerForm TypeView
05/23/2024
5:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
6:53 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:41 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:14 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:06 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:01 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:06 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
5:05 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
8:31 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
5:10 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
5:05 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:16 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
7:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:54 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:55 PM
Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:56 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:57 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
9:06 AM
Brainstorm Cell Therapeutics (Subject)
Ness Kevin Dean (Filed by)
Form SC 13G/A
12/20/2023
4:04 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
5:03 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
4:28 PM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
10/24/2023
6:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
4:16 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
6:31 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:31 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:21 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
5:02 AM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
8:28 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/21/2023
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2023
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:58 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BCLI) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners